{
    "id": "1208",
    "question": "Which of the following patient presentations seen in a pediatric immunology clinic is most consistent with a diagnosis of Bruton's agammaglobulinemia?",
    "options": {
        "A": "A 15-month-old girl who has had repeated otitis media, pneumonia, and progressive clumsiness since beginning to walk in the past three months",
        "B": "A 10-month-old boy who has had recurrent viral infections as well as hypocalcemia during neonatal period",
        "C": "A 4-year-old girl who has had repeated oral candidasis in the past nine months",
        "D": "A 9-month-old boy who has had recurrent otitis media and pneumococcal pneumonia in the past three months"
    },
    "answer": "D",
    "predict": "{\"step_by_step_thinking\": \"To determine the most consistent patient presentation with a diagnosis of Bruton's agammaglobulinemia, let's analyze each option given the characteristics of the disease. Bruton's agammaglobulinemia, also known as X-linked agammaglobulinemia, is a genetic disorder characterized by the failure of pre-B cells to differentiate into mature B cells, leading to a severe deficiency in antibody production and a resultant absence of immunoglobulins in the blood. This disease primarily affects males due to its X-linked inheritance pattern. Common manifestations of Bruton's agammaglobulinemia include recurrent infections, particularly with encapsulated bacteria such as Streptococcus pneumoniae and Haemophilus influenzae type b, and a susceptibility to infections due to the lack of antibodies to protect against these pathogens. The disease typically presents in the first six months of life, with symptoms such as recurrent infections, developmental delays, and poor immune response to vaccinations. Let's examine each option in the context of these characteristics: A. A 15-month-old girl who has had repeated otitis media, pneumonia, and progressive clumsiness since beginning to walk in the past three months: While this presentation could be consistent with various immune deficiencies, the gender of the patient (female) does not align with the X-linked inheritance pattern of Bruton's agammaglobulinemia. Moreover, the progression of symptoms described does not specifically point towards a B-cell deficiency. B. A 10-month-old boy who has had recurrent viral infections as well as hypocalcemia during the neonatal period: The presence of hypocalcemia during the neonatal period is not a typical presentation of Bruton's agammaglobulinemia. While recurrent viral infections could be seen in a patient with a compromised immune system, the combination of hypocalcemia and viral infections does not specifically point towards Bruton's agammaglobulinemia. C. A 4-year-old girl who has had repeated oral candidasis in the past nine months: Oral candidiasis can be seen in patients with various immune deficiencies, including those with T-cell immunodeficiencies. However, the gender of the patient (female) does not align with the X-linked inheritance pattern of Bruton's agammaglobulinemia. D. A 9-month-old boy who has had recurrent otitis media and pneumococcal pneumonia in the past three months: This option aligns with the typical presentation of Bruton's agammaglobulinemia, particularly the recurrent infections with encapsulated bacteria such as Streptococcus pneumoniae and Haemophilus influenzae type b. The age of the patient (9 months) also fits within the common timeframe for the presentation of Bruton's agammaglobulinemia. Given the information provided, option D is the most consistent with a diagnosis of Bruton's agammaglobulinemia. answer_choice\": \"D\"}}",
    "snippets": [
        {
            "id": "Pathology_Robbins_993",
            "title": "Pathology_Robbins",
            "content": "X-linked agammaglobulinemia (XLA), or Bruton disease, is characterized by the failure of pre\u2013B cells to differentiate into mature B cells and, as the name implies, a resultant absence of antibodies (gamma globulin) in the blood."
        },
        {
            "id": "Immunology_Janeway_3098",
            "title": "Immunology_Janeway",
            "content": "The first description of an immunodeficiency disease was Ogden C. Bruton\u2019s account, in 1952, of the failure of a male child to produce antibody. Because inheritance of this condition is Xlinked and is characterized by the absence of immunoglobulin in the serum (agammaglobulinemia), it was called Bruton\u2019s Xlinked agammaglobulinemia (XLA) (see Fig. 13.2). Since then, autosomal recessive variants of agammaglobulinemia have been described. Infants with these diseases are usually identified as a result of recurrent infections with pyogenic bacteria, such as Streptococcus pneumoniae, and enteroviruses. In this regard, it should be noted that normal infants have a transient deficiency in immunoglobulin production in the first 3\u201312 months of life. The newborn infant has antibody levels comparable to those of the mother because of the transplacental transport of maternal IgG (see Section 1017). As this IgG is catabolized, antibody levels gradually decrease until the infant begins to produce"
        },
        {
            "id": "InternalMed_Harrison_24827",
            "title": "InternalMed_Harrison",
            "content": "agammaglobulinemia Agammaglobulinemia is characterized by a profounddefectinBcelldevelopment(<1%ofthenormalBcellblood count). In most patients, very low residual Ig isotypes can be detected in the serum. In 85% of cases, agammaglobulinemia is caused by a mutation in the BTK gene that is located on the X chromosome. The BTK gene product is a kinase that participates in (pre) B cell receptor signaling. When the kinase is defective, there is a block (albeit a leaky one) at the pre-B to B cell stage (Fig. 374-4). Detection of BTK by intracellular immunofluorescence of monocytes, and lack thereof in patients with X-linked agammaglobulinemia, is a useful diagnostic test. Not all of the mutations in BTK result in agammaglobulinemia, since some patients have a milder form of hypogammaglobulinemia and low but detectable B cell counts. These cases should not be confused with common variable immunodeficiency (CVID, see below). About 10% of agammaglobulinemia cases are caused by alterations in"
        },
        {
            "id": "Pediatrics_Nelson_1641",
            "title": "Pediatrics_Nelson",
            "content": "Available @ StudentConsult.com Disorders of B cells result in an increased susceptibility to infections by encapsulated bacteria. Agammaglobulinemia results from the absence or defective function of B cells with subsequent severe decrease in immunoglobulin levels and a total absence of specific antibody. X-linked agammaglobulinemia affects males and is characterized by a profound deficiency of B cells, severe hypogammaglobulinemia, and absence of lymphoid tissue (Table 73-1; see Fig. 73-1). The defect is caused by mutations in a gene encoding the tyrosine kinase Btk on chromosome Xq22 that is involved in a signaling of the pre-B-cell receptor and the B-cell antigen receptor. Autosomal recessive agammaglobulinemiaresults from a variety of defects in the pre-B-cell and B-cell antigen receptor complexes and includes mutations in the \u03bc heavy chain gene, \u03bb5, Ig\u03b1, Ig\u03b2, and BLNK. X-linked agammaglobulinemia is more common than the autosomal recessive forms."
        },
        {
            "id": "Pathology_Robbins_999",
            "title": "Pathology_Robbins",
            "content": "The treatment of X-linked agammaglobulinemia is replacement therapy with intravenous immunoglobulin (IVIG) from pooled human serum. DiGeorge syndrome is caused by a congenital defect in thymic development resulting in deficient T-cell maturation. T cells are absent in the lymph nodes, spleen, and peripheral blood, and infants with this defect are extremely vulnerable to viral, fungal, and protozoal infections. Patients also are susceptible to infection with intracellular bacteria, because of defective T cell\u2013mediated immunity. B cells and serum immunoglobulins are generally unaffected."
        },
        {
            "id": "First_Aid_Step2_924",
            "title": "First_Aid_Step2",
            "content": "B cell X-linked agamma-globulinemia (Bruton\u2019s) Common variable immunodef ciency IgA def ciency A B-cell def ciency in boys only. Immunoglobulin level drops in the 20s and 30s; usually a combined Band T-cell defect. Mild; the most common immunodef ciency. Life threatening; encapsulated Pseudomonas, Streptococcus pneumoniae, and Haemophilus infections after six months (passive immunity through maternal antibodies wanes). \u2191 pyogenic upper and lower respiratory infections; \u2191 risk of lymphoma and autoimmune disease. Usually asymptomatic; patients may develop recurrent respiratory or GI infections. Anaphylactic transfusion reaction due to anti-IgA antibodies is a common presentation. Quantitative immunoglobulin levels. If low, conf rm diagnosis with Band T-cell subsets (absent B cells; T cells are often high); absent tonsils and other lymphoid tissue may be a clue. Treat with prophylactic antibiotics and IVIG. Quantitative immunoglobulin levels; confrm with Band T-cell subsets; treat with"
        },
        {
            "id": "Pediatrics_Nelson_1621",
            "title": "Pediatrics_Nelson",
            "content": "Age of onset of symptoms can be helpful in defining animmune deficiency, although significant variability does occur. Neutrophil defects (e.g., congenital neutropenia, leukocyte adhesion deficiency) typically present in the first severalmonths of life. Antibody defects (e.g., agammaglobulinemia)and T-cell defects (e.g., severe combined immunodeficiency[SCID]) typically present after 3 months of life after maternal antibody levels have waned. Presentation with symptomsof an antibody deficiency in adolescence or young adulthoodsuggests common variable immunodeficiency (CVID) ratherthan agammaglobulinemia, although milder phenotypes ofprimary immunodeficiency disease may not present until later"
        },
        {
            "id": "InternalMed_Harrison_24828",
            "title": "InternalMed_Harrison",
            "content": "and low but detectable B cell counts. These cases should not be confused with common variable immunodeficiency (CVID, see below). About 10% of agammaglobulinemia cases are caused by alterations in genes encoding elements of the pre-B cell receptor, i.e., the \u03bc heavy chain, the \u03bb5 surrogate light chain, Ig\u03b1 or Ig\u03b2, the scaffold protein BLNK, and the p85 \u03b1 subunit of phosphatidylinositol 3 phosphate kinase (P13K). In 5% of cases, the defect is unknown. It is noteworthy that agammaglobulinemia can be observed in patients with ICF syndrome, despite the presence of normal peripheral B cell counts. 2111 Lastly, agammaglobulinemia can be a manifestation of a myelodysplastic syndrome (associated or not with neutropenia). Treatment of agammaglobulinemic patients is based on immunoglobulin replacement (see below). Profound hypogammaglobulinemia is also observed in adults, in association with thymoma."
        },
        {
            "id": "Immunology_Janeway_4592",
            "title": "Immunology_Janeway",
            "content": "bronchus-associated lymphoid tissue (BALT) Organized lymphoid tissue found in the bronchi in some animals. Adult humans do not normally have such organized lymphoid tissue in the respiratory tract, but it may be present in some infants and children. Bruton\u2019s tyrosine kinase (Btk) A Tec-family tyrosine kinase important in B-cell receptor signaling. Btk is mutated in the human immunodeficiency disease X-linked agammaglobulinemia. Bruton\u2019s X-linked agammaglobulinemia See X-linked agammaglobulinemia. bursa of Fabricius Lymphoid organ associated with the gut that is the site of B-cell development in chickens. butyrate A short chain fatty acid produced abundantly by anaerobic digestion of carbohydrates in the intestine by commensals that can in\ufb02uence host cells in several ways, acting as an energy source for enterocytes and as an inhibitor of histone deacetylases."
        },
        {
            "id": "Pediatrics_Nelson_1642",
            "title": "Pediatrics_Nelson",
            "content": "Patients with agammaglobulinemia usually present during the first 6 to 12 months of life as maternally derived antibodies wane, although patients can present years later. These patients develop infections with Streptococcus pneumoniae, Haemophilus influenzae type b, Staphylococcus aureus, and Pseudomonas, organisms for which antibody is an important opsonin. They also have increased susceptibility to giardiasis and enteroviral infections, leading to chronic enteroviral meningoencephalitis and vaccine-associated poliomyelitis (if immunized with oral live, attenuated poliovirus vaccine)."
        },
        {
            "id": "Pathology_Robbins_1007",
            "title": "Pathology_Robbins",
            "content": "Patients typically present with recurrent sinopulmonary bacterial infections. About 20% of patients have recurrent herpesvirus infections, and serious enterovirus infections causing meningoencephalitis also may occur. Individuals with this disorder also are prone to the development of persistent diarrhea caused by G. lamblia. In contrast to X-linked agammaglobulinemia, common variable immunodeficiency affects both sexes equally, and the onset of symptoms is later, in childhood or adolescence. As in X-linked agammaglobulinemia, these patients have a high frequency of autoimmune diseases (approximately 20%), including rheumatoid arthritis. The risk for lymphoid malignancy also is increased, and an increase in gastric cancer has been reported."
        },
        {
            "id": "InternalMed_Harrison_24826",
            "title": "InternalMed_Harrison",
            "content": "Diagnosis of B cell PIDs relies on the determination of serum Ig levels (Table 316-2). Determination of antibody production following immunization with tetanus toxoid vaccine or nonconjugated pneumococcal polysaccharide antigens can also help diagnose more subtle deficiencies. Another useful test is B cell phenotype determination in switched \u03bc\u2212\u03b4\u2212 CD27+ and nonswitched memory B cells (\u03bc+\u03b4+ CD27+). In agammaglobulinemic patients, examination of bone marrow B cell precursors (Fig. 374-4) can help obtain a precise diagnosis and guide the choice of genetic tests."
        },
        {
            "id": "Immunology_Janeway_4533",
            "title": "Immunology_Janeway",
            "content": "Compiled by Joost Oppenheim, National Cancer Institute, NIH. Emil von Behring (1854\u20131917) discovered antitoxin antibodies with Shibasaburo Kitasato. Baruj Benacerraf (1920\u20132011) discovered immune response genes and collaborated in the first demonstration of MHC restriction. Bruce Beutler (1957\u2013) discovered the role of the Toll-like receptor in innate immunity in mice. Jules Bordet (1870\u20131961) discovered complement as a heat-labile component in normal serum that would enhance the antimicrobial potency of specific antibodies. Ogden C. Bruton (1908\u20132003) documented the first description of an immunodeficiency disease describing the failure of a male child to produce antibody. Because inheritance of this condition is X-linked and is characterized by the absence of immunoglobulin in the serum (agammaglobulinemia), it was called Bruton\u2019s X-linked agammaglobulinemia."
        },
        {
            "id": "Pediatrics_Nelson_1697",
            "title": "Pediatrics_Nelson",
            "content": "Autoimmune neutropenia usually develops in children 5 to 24 months of age and often persists for prolonged periods. Neutrophil autoantibodies may be IgG, IgM, IgA, or a combination of these. Usually the condition resolves in 6 months to 4 years. Although intravenous immune globulin and corticosteroids have been used, most patients respond to G-CSF. Autoimmune neutropenia rarely may be an early manifestation of systemic lupus erythematosus, rheumatoid arthritis, or autoimmune lymphoproliferative disease. Disorders of Neutrophil Migration"
        },
        {
            "id": "InternalMed_Harrison_24829",
            "title": "InternalMed_Harrison",
            "content": "Hyper-IgM (HIGM) Syndromes HIGM is a rare B cell PID characterized by defective Ig CSR. It results in very low serum levels of IgG and IgA and elevated or normal serum IgM levels. The clinical severity is similar to that seen in agammaglobulinemia, although chronic lung disease and sinusitis are less frequent and enteroviral infections are uncommon. As discussed above, a diagnosis of HIGM involves screening for an X-linked CD40L deficiency and an autosomal recessive CD40 deficiency, which affect both B and T cells. In 50% of cases affecting only B cells, these isolated HIGM syndromes result from mutations in the gene encodingactivation-induceddeaminase,theproteinthatinducesCSRin B cell germinal centers. These patients usually have enlarged lymphoid organs. In the other 50% of cases, the etiology is unknown (except for rareUNGandPMS2deficiencies).Furthermore,IgM-mediatedautoimmunity and lymphomas can occur in HIGM syndrome. It is noteworthy that HIGM can result from fetal rubella"
        },
        {
            "id": "Pediatrics_Nelson_1650",
            "title": "Pediatrics_Nelson",
            "content": "IgG subclass deficiency occurs when the level of antibod-Specific antibody deficiency syndrome is characterized by ies in one or more of the four IgG subclasses is selectively recurrent infections with normal immunoglobulin levels and Agammaglobulinemia X-linked, AR Infancy (6\u20139 Recurrent infections, Arrest in B-cell Lymphoid hypoplasia mo) sinusitis, pneumonia, differentiation (pre-B level); meningitis (encapsulated mutations in: Btk gene bacteria, enteroviruses) (X-linked); \u03bc chain, BLNK, Ig\u03b1, Ig\u03b2, Vpre-B, and \u03bb5 (AR) Hyper-IgM syndrome AR Variable Sinopulmonary infections Defect in AID, UNG Autoimmunity AD, Autosomal dominant; AID, activation-induced cytidine deaminase; AR, autosomal recessive; ITP, idiopathic thrombocytopenic purpura; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; UNG, uracil-DNA glycosylase."
        },
        {
            "id": "Pediatrics_Nelson_1640",
            "title": "Pediatrics_Nelson",
            "content": "Disorders that affect lymphocyte development or function result in significant immunodeficiency because lymphocytes provide antigen specificity and memory responses. Hematopoietic stem cells give rise to lymphoid precursors that develop into T lymphocytes in the thymus or B lymphocytes in the bone marrow (Fig. 73-1). Isolated B-cell disorders result in antibody deficiency diseases, whereas T-cell disorders usually cause combined immunodeficiency because they are necessary for cell-mediated immunity to clear intracellular pathogens and for antibody synthesis by B cells. NK cells are an important component of the innate immune response, develop from lymphoid precursors, and can kill virus-infected cells and tumor cells. Antibodies can enhance NK cell function by antibody-mediated cellular cytotoxicity. Available @ StudentConsult.com Disorders of B cells result in an increased susceptibility to infections by encapsulated bacteria."
        },
        {
            "id": "InternalMed_Harrison_25002",
            "title": "InternalMed_Harrison",
            "content": "of nonpathogenic IgM auto-antibodies to the production of pathogenic IgG autoantibodies in the absence of antigen-specific T cell help. Aberrant selection of the B or T cell repertoire at the time of antigen receptor expression can also predispose to autoimmunity. For example, B cell immunodeficiency caused by an absence of the B cell receptor\u2013associated kinase (Bruton\u2019s tyrosine kinase) leads to X-linked agammaglobulinemia. This syndrome is characterized by reduced B cell numbers. This leads to high levels of BAFF which alter B cell selection and lead to greater survival of autoreactive B cells. Likewise, negative selection of autoreactive T cells in the thymus requires expression of the autoimmune regulator (AIRE) gene that enables the expression of tissue-specific proteins in thymic medullary epithelial cells. Peptides from these proteins are expressed in the context of major histocompatibility complex (MHC) molecules and mediate the central deletion of autoreactive T cells. The"
        },
        {
            "id": "Immunology_Janeway_203",
            "title": "Immunology_Janeway",
            "content": "1.7 Matching: match each of the following terms to the numbered phrase that describes it best: A. Allergy __ 1. Immunological response to an antigen present on a transplanted foreign cell B. Immunological 2. Immunological response tolerance __ to an antigen that is an innocuous foreign substance C. Autoimmune 3. Immunological process disease __ that prevents an immune response to self antigens D. graft rejection __ 4. Immunological response to a self antigen 1.8 Multiple Choice: Which of the following processes is not a mechanism of maintaining immunologic tolerance? A. Clonal deletion B. Anergy C. Clonal expansion D. Suppression of self-reactive lymphocytes 1.9 Matching: Classify each of the following as a central/ primary or peripheral/secondary lymphoid organ: A. Bone marrow B. lymph node C. Spleen D. thymus E. Appendix 1.10 Matching: match the following region, structure, or subcompartments with the numbered organ they are present in: A. lymph node __ B. Spleen __"
        },
        {
            "id": "Pathology_Robbins_1004",
            "title": "Pathology_Robbins",
            "content": "http://ebooksmedicine.net This relatively frequent but poorly defined entity encompasses a heterogeneous group of disorders in which the common feature is hypogammaglobulinemia, generally affecting all the antibody classes but sometimes only IgG. The diagnosis of common variable immunodeficiency is based on exclusion of other well-defined causes of decreased antibody production. The estimated prevalence of the disease is about 1 in 50,000."
        },
        {
            "id": "Pediatrics_Nelson_1643",
            "title": "Pediatrics_Nelson",
            "content": "Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by hypogammaglobulinemia developing after an initial period of normal immune function, most commonly in the second and third decades of life (see Table 73-1). Serum IgG levels are less than 500 mg/dL (usually <300 mg/dL) with IgA levels less than 10 mg/dL and/or low IgM levels. Antibody titers to protein antigens, suchas tetanus and diphtheria, and to polysaccharide antigens,such as pneumococcus, are low or absent. T-cell numbersand function are highly variable, and B-cell numbers can be normal or low. Patients exhibit normal-sized or enlargedtonsils and lymph nodes and may have splenomegaly. Theyare susceptible to frequent respiratory tract infections due to Streptococcus pneumoniae, Haemophilus influenzae type b, and Mycoplasma. Gastrointestinal infections with Giardia, Campylobacter, Salmonella, Helicobacter, and enteroviruses are common. Autoimmune hemolytic anemia and thrombocytopenia occur"
        },
        {
            "id": "Pediatrics_Nelson_1647",
            "title": "Pediatrics_Nelson",
            "content": "of infancy is a temas well as other causes of hypogammaglobulinemia, such as porary condition characterized by delayed immunoglobulin hypogammaglobulinemia associated with thymoma, second-production. The pathogenesis of this disorder is unknown ary to protein losing enteropathy, or secondary to medica-but is thought to result from a prolongation of the physiologic tions, before making the diagnosis of CVID. hypogammaglobulinemia of infancy. The immunoglobulin"
        },
        {
            "id": "Pediatrics_Nelson_1646",
            "title": "Pediatrics_Nelson",
            "content": "The gene defects leading to the majority of cases of CVID decreased while total IgG levels are normal. Normal indiare unknown. Some patients have a defect in the gene encod-viduals can express low levels of one or more subclasses, so ing for inducible co-stimulator (ICOS) on activated T cells, a history of recurrent infections is important. An inability to transmembrane activator and calcium-modulating cyclophi-synthesize specific antibody titers to protein or polysaccharide lin ligand interactor (TACI), CD19, CD21, CD81, or BAFF-R. antigens is the best marker of IgG subclass deficiency associ-It is important to exclude X-linked agammaglobulinemia, ated with recurrent infections and requiring therapy. X-linked lymphoproliferative disease, or hyper-IgM syndrome Transient hypogammaglobulinemia of infancy is a temas well as other causes of hypogammaglobulinemia, such as porary condition characterized by delayed immunoglobulin hypogammaglobulinemia associated with thymoma,"
        },
        {
            "id": "Immunology_Janeway_3409",
            "title": "Immunology_Janeway",
            "content": "Grusby, M.J., and Glimcher, L.H.: Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 1995, 13:417\u2013435. Pignata, C., Gaetaniello, L., Masci, A.M., Frank, J., Christiano, A., Matrecano, E., and Racioppi, L.: Human equivalent of the mouse Nude/SCID phenotype: longterm evaluation of immunologic reconstitution after bone marrow transplantation. Blood 2001, 97:880\u2013885. Steimle, V., Reith, W., and Mach, B.: Major histocompatibility complex class II deficiency: a disease of gene regulation. Adv. Immunol. 1996, 61:327\u2013340. production that cause an inability to clear extracellular bacteria and some viruses. Bruton, O.C.: Agammaglobulinemia. Pediatrics 1952, 9:722\u2013728. Conley, M.E.: Genetics of hypogammaglobulinemia: what do we really know? Curr. Opin. Immunol. 2009, 21:466\u2013471. Lee, M.L., Gale, R.P., and Yap, P.L.: Use of intravenous immunoglobulin to prevent or treat infections in persons with immune deficiency. Annu. Rev. Med. 1997, 48:93\u2013102."
        },
        {
            "id": "Immunology_Janeway_3081",
            "title": "Immunology_Janeway",
            "content": "syndrome, and there is activation and clonal expansion of the limited number of specificities present. The clinical features strongly suggest that these peripheral T cells are autoreactive and are responsible for the graftversushost phenotype. In addition to Omenn syndrome, which is manifested very early in life, other forms of immunodeficiency have also been associated with reduced but not absent RAG activity, and are often characterized by granulomatous disease that is not evident until late childhood or adolescence."
        },
        {
            "id": "Immunology_Janeway_3117",
            "title": "Immunology_Janeway",
            "content": "Other examples of predominantly antibody deficiency include the most common forms of primary immunodeficiency, referred to as common variable immunodeficiencies (CVIDs). CVIDs are a clinically and genetically heterogeneous group of disorders that typically go undiagnosed until late childhood or adulthood, because the immune deficiency is relatively mild. Unlike other causes of immunoglobulin deficiency, patients with CVID can have defects in immunoglobulin production that are limited to one or more isotypes (see Fig. 13.5). IgA deficiency, the most common primary immunodeficiency, exists in both sporadic and familial forms, and both autosomal recessive and autosomal dominant inheritance have been described. The etiology of IgA deficiency in most patients is not understood, and these patients are asymptomatic. In IgAdeficient patients who do develop recurrent infections, an associated defect in one of the IgG subclasses is often found."
        },
        {
            "id": "InternalMed_Harrison_8665",
            "title": "InternalMed_Harrison",
            "content": "Two popular staging systems have been developed to reflect these prognostic groupings (Table 134-7). Patients with typical B-cell CLL can have their course complicated by immunologic abnormalities, including autoimmune hemolytic anemia, autoimmune thrombocytopenia, and hypogammaglobulinemia. Patients with hypogammaglobulinemia benefit from regular (monthly) \u03b3 globulin administration. Because of expense, \u03b3 globulin is often withheld until the patient experiences a significant infection. These abnormalities do not have a clear prognostic significance and should not be used to assign a higher stage."
        },
        {
            "id": "Pediatrics_Nelson_3246",
            "title": "Pediatrics_Nelson",
            "content": "Laboratory Diagnosis. The peripheral blood smear in autoimmune hemolytic anemia usually reveals spherocytes and occasionally nucleated RBCs. The reticulocyte count varies because some patients have relatively low reticulocyte counts as a result of autoantibodies that cross-react with RBC precursors. Treatment and Prognosis. Transfusion for the treatment of autoimmune hemolysis is challenging because crossmatching is difficult, as the autoantibodies react with virtually all RBCs. In addition to transfusion, which may be lifesaving, management of autoimmune hemolytic anemia depends on antibody type. Management may involve administration of corticosteroids and, at times, intravenous immunoglobulin. Corticosteroids reduce the clearance of sensitized RBCs in the spleen. In drug-induced hemolysis, withdrawal of the drug usually leads to resolution of the hemolytic process. More than 80% of children with autoimmune hemolytic anemia recover spontaneously."
        },
        {
            "id": "Immunology_Janeway_3405",
            "title": "Immunology_Janeway",
            "content": "Leonard, W.J.: The molecular basis of X linked severe combined immuno-13-8 Defects in B-cell development result in deficiencies in antibody deficiency. Annu. Rev. Med. 1996, 47:229\u2013239. Leonard, W.J.: Cytokines and immunodeficiency diseases. Nat. Rev. Immunol. 2001, 1:200\u2013208. Stephan, J.L., Vlekova, V., Le Deist, F., Blanche, S., Donadieu, J., De Saint-Basile, G., Durandy, A., Griscelli, C., and Fischer, A.: Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J. Pediatr. 1993, 123:564\u2013572. 13-4 SCID can also be due to defects in the purine salvage pathway. Hirschhorn, R.: Adenosine deaminase deficiency: molecular basis and recent developments. Clin. Immunol. Immunopathol. 1995, 76:S219\u2013S227. 13-5 Defects in antigen receptor gene rearrangement can result in SCID. Bosma, M.J., and Carroll, A.M.: The SCID mouse mutant: definition, characterization, and potential uses. Annu. Rev. Immunol. 1991, 9:323\u2013350."
        },
        {
            "id": "InternalMed_Harrison_8743",
            "title": "InternalMed_Harrison",
            "content": "A number of specific clinical syndromes are seen in the peripheral T-cell lymphomas. Angioimmunoblastic T-cell lymphoma is one of the more common subtypes, making up ~20% of T-cell lymphomas. These patients typically present with generalized lymphadenopathy, fever, weight loss, skin rash, and polyclonal hypergammaglobulinemia. In some cases, it is difficult to separate patients with a reactive disorder from those with true lymphoma."
        },
        {
            "id": "InternalMed_Harrison_8361",
            "title": "InternalMed_Harrison",
            "content": "PRCA has important associations with immune system diseases. A small minority of cases occur with a thymoma. More frequently, red cell aplasia can be the major manifestation of large granular lymphocytosis or complicate chronic lymphocytic leukemia. Some patients may be hypogammaglobulinemic. Infrequently (compared to agranulocytosis), PRCA can be due to an idiosyncratic drug reaction. Subcutaneous administration of erythropoietin (EPO) has provoked PRCA mediated by neu-CD tralizing antibodies. FIGURE 130-2 Pathognomonic cells in marrow failure syndromes. A. Giant pronormoblast, the"
        },
        {
            "id": "First_Aid_Step2_374",
            "title": "First_Aid_Step2",
            "content": "ITP is associated with a range of conditions, including lymphoma, leukemia, SLE, HIV, and HCV. The clinical presentation is as follows: Acute: Abrupt onset of hemorrhagic complications following a viral illness. Commonly affects children 2\u20136 years of age, with males and females affected equally. Chronic: Insidious onset that is unrelated to infection. Most often affects adults 20\u201340 years of age; women are three times more likely to be affected than men. A diagnosis of exclusion, as the test for platelet-associated antibodies is a poor one. Once other causes of thrombocytopenia have been ruled out, a diagnosis can be made on the basis of the history and physical, a CBC, and a peripheral blood smear showing normal RBC morphology. Most patients do not require bone marrow biopsy, which would show \u2191 megakaryocytes as the only abnormality. Most patients with acute childhood ITP spontaneously remit, but this is rarely the case in chronic ITP."
        }
    ],
    "scores": [
        0.03847765249138946,
        0.03538667518073661,
        0.0345630476211338,
        0.02932029628302197,
        0.028023383266350017,
        0.02641048272116233,
        0.025767250767250765,
        0.025583401181487306,
        0.024153476861023065,
        0.022270400854826594,
        0.021777782827149587,
        0.021765548244421486,
        0.021718054128126073,
        0.018006213882951587,
        0.017545209696036936,
        0.01709773237701949,
        0.01642068873819971,
        0.01628707627118644,
        0.01628707627118644,
        0.01588557516737675,
        0.015669856459330143,
        0.015639980824544583,
        0.015385525770755665,
        0.01526840244294439,
        0.015205627705627707,
        0.014685756395410043,
        0.014609094535301157,
        0.01455538996522603,
        0.01452020202020202,
        0.01438990735265129,
        0.014112715416860735,
        0.014054744704899504
    ]
}